|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
84,571,000 |
Market
Cap: |
189.44(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.7304 - $3.24 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Esperion Therapeutics is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Co.'s first two products were approved by the U.S. Food and Drug Administration, European Medicines Agency, and Swiss Agency for Therapeutic Products. Bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
74,217 |
Total Buy Value |
$0 |
$0 |
$0 |
$171,738 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
7 |
Total Shares Sold |
192 |
192 |
1,886 |
51,771 |
Total Sell Value |
$477 |
$477 |
$2,807 |
$239,075 |
Total People Sold |
1 |
1 |
1 |
4 |
Total Sell Transactions |
1 |
1 |
5 |
26 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Foody Joanne M. |
Chief Medical Officer |
|
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
277,064 |
|
- |
|
Warren Eric |
Chief Commercial Officer |
|
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
168,318 |
|
- |
|
Looker Benjamin |
General Counsel |
|
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
183,663 |
|
- |
|
Halladay Benjamin |
Chief Financial Officer |
|
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
243,936 |
|
- |
|
Koenig Sheldon L. |
President and CEO |
|
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
454,000 |
766,816 |
|
- |
|
Warren Eric |
Chief Commercial Officer |
|
2023-09-20 |
4 |
S |
$1.25 |
$924 |
D/D |
(742) |
68,318 |
|
-76% |
|
Warren Eric |
Chief Commercial Officer |
|
2023-08-18 |
4 |
S |
$1.41 |
$344 |
D/D |
(243) |
69,060 |
|
-95% |
|
Warren Eric |
Chief Commercial Officer |
|
2023-07-19 |
4 |
S |
$1.59 |
$168 |
D/D |
(106) |
69,303 |
|
19% |
|
Warren Eric |
Chief Commercial Officer |
|
2023-06-21 |
4 |
S |
$1.48 |
$894 |
D/D |
(603) |
69,409 |
|
45% |
|
Carroll J Martin |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
41,650 |
|
- |
|
Rocamboli Stephen |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
13,261 |
|
- |
|
Woody Tracy M |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
33,566 |
|
- |
|
Fuhrman Alan |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
30,404 |
|
- |
|
Fischer Seth H.z. |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
5,150 |
|
- |
|
Vitullo Nicole |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
36,918 |
|
- |
|
Gotto Antonio M Jr MD D Phil |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
28,599 |
|
- |
|
Shepard Jay |
Director |
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
28,599 |
|
- |
|
Warren Eric |
Chief Commercial Officer |
|
2023-05-17 |
4 |
S |
$1.62 |
$356 |
D/D |
(219) |
70,012 |
|
40% |
|
Carroll J Martin |
Director |
|
2023-05-11 |
4 |
B |
$1.57 |
$36,285 |
D/D |
23,091 |
36,500 |
2.39 |
-23% |
|
Carroll J Martin |
Director |
|
2023-05-10 |
4 |
B |
$1.49 |
$12,545 |
D/D |
8,409 |
13,409 |
2.39 |
-15% |
|
Rocamboli Stephen |
Director |
|
2023-05-10 |
4 |
B |
$1.50 |
$12,126 |
D/D |
8,111 |
8,111 |
2.39 |
-15% |
|
Koenig Sheldon L. |
President and CEO |
|
2023-05-09 |
4 |
B |
$1.26 |
$25,192 |
D/D |
20,000 |
312,816 |
2.81 |
-9% |
|
Foody Joanne M. |
Chief Medical Officer |
|
2023-04-19 |
4 |
S |
$1.27 |
$1,192 |
D/D |
(938) |
127,064 |
|
-21% |
|
Warren Eric |
Chief Commercial Officer |
|
2023-04-19 |
4 |
S |
$1.28 |
$147 |
D/D |
(115) |
70,231 |
|
-21% |
|
Looker Benjamin |
General Counsel |
|
2023-04-19 |
4 |
S |
$1.27 |
$1,641 |
D/D |
(1,290) |
83,663 |
|
-21% |
|
204 Records found
|
|
Page 1 of 9 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|